<DOC>
	<DOCNO>NCT00670436</DOCNO>
	<brief_summary>The aim study assess safety efficacy Paclitaxel-eluting PTCA-balloon combination bare-metal stenting treatment chronic total occlusion native coronary artery reference diameter 2.5 mm 4.0 mm .</brief_summary>
	<brief_title>The Paclitaxel-Eluting Percutaneous Transluminal Coronary Angioplasty ( PTCA ) - Balloon Catheter Coronary Artery Disease Treat Chronic Total Occlusions</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>chronic total occlusion Thrombolysis Myocardial Infarction ( TIMI ) flow 0 1 occlusion native coronary artery indication percutaneous coronary intervention base symptom , prognosis evidence ischemia reference diameter 2.5 mm 4.0 mm saphenous vein graft bifurcation lesion need stent main side branch leave main occlusion denovo stenosis ( occlusion ) restenosis instent restenosis contraindication dual antiplatelet therapy acetylsalicylic acid clopidogrel 6 month coronary aneurysm target lesion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>